Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $89,468 | 24 | 52.4% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $53,321 | 8 | 31.2% |
| Travel and Lodging | $20,214 | 22 | 11.8% |
| Unspecified | $6,255 | 1 | 3.7% |
| Food and Beverage | $1,621 | 15 | 0.9% |
Payments by Type
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| SANOFI-AVENTIS U.S. LLC | $135,096 | 50 | $0 (2024) |
| Eli Lilly and Company | $7,369 | 4 | $0 (2017) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $6,379 | 4 | $0 (2024) |
| Merck Sharp & Dohme Corporation | $5,100 | 1 | $0 (2021) |
| Vertex Pharmaceuticals Incorporated | $4,034 | 3 | $0 (2023) |
| PFIZER INC. | $3,980 | 2 | $0 (2019) |
| Biogen, Inc. | $3,675 | 1 | $0 (2020) |
| Novo Nordisk AS | $2,380 | 1 | $0 (2021) |
| E.R. Squibb & Sons, L.L.C. | $1,556 | 2 | $0 (2017) |
| GlaxoSmithKline, LLC. | $1,310 | 2 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $68,149 | 24 | SANOFI-AVENTIS U.S. LLC ($65,139) |
| 2023 | $74,510 | 31 | SANOFI-AVENTIS U.S. LLC ($69,957) |
| 2021 | $7,480 | 2 | Merck Sharp & Dohme Corporation ($5,100) |
| 2020 | $7,044 | 4 | Biogen, Inc. ($3,675) |
| 2019 | $3,980 | 2 | PFIZER INC. ($3,980) |
| 2017 | $9,716 | 7 | Eli Lilly and Company ($7,369) |
All Payment Transactions
70 individual payment records from CMS Open Payments — Page 1 of 3
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | SANOFI-AVENTIS U.S. LLC | — | Consulting Fee | Cash or cash equivalent | $967.50 | General |
| 11/05/2024 | SANOFI-AVENTIS U.S. LLC | — | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $11,610.00 | General |
| 11/05/2024 | SANOFI-AVENTIS U.S. LLC | — | Travel and Lodging | Cash or cash equivalent | $3,225.71 | General |
| 11/05/2024 | SANOFI-AVENTIS U.S. LLC | — | Travel and Lodging | Cash or cash equivalent | $481.88 | General |
| 11/05/2024 | SANOFI-AVENTIS U.S. LLC | — | Travel and Lodging | Cash or cash equivalent | $105.00 | General |
| 11/05/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $67.13 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/05/2024 | SANOFI-AVENTIS U.S. LLC | — | Travel and Lodging | Cash or cash equivalent | $27.11 | General |
| 10/18/2024 | SANOFI-AVENTIS U.S. LLC | — | Consulting Fee | Cash or cash equivalent | $645.00 | General |
| 09/05/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | — | Consulting Fee | Cash or cash equivalent | $3,010.00 | General |
| 08/29/2024 | SANOFI-AVENTIS U.S. LLC | — | Consulting Fee | Cash or cash equivalent | $1,935.00 | General |
| 08/12/2024 | SANOFI-AVENTIS U.S. LLC | — | Consulting Fee | Cash or cash equivalent | $645.00 | General |
| 07/03/2024 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Consulting Fee | Cash or cash equivalent | $1,182.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 07/02/2024 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Consulting Fee | Cash or cash equivalent | $1,180.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Consulting Fee | Cash or cash equivalent | $4,837.50 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Travel and Lodging | In-kind items and services | $601.03 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Travel and Lodging | In-kind items and services | $338.63 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $191.97 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Travel and Lodging | Cash or cash equivalent | $60.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 06/20/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | Cash or cash equivalent | $15.39 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/20/2024 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Consulting Fee | Cash or cash equivalent | $886.50 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/17/2024 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Consulting Fee | Cash or cash equivalent | $886.50 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/11/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $11,610.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/09/2024 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Consulting Fee | Cash or cash equivalent | $11,820.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 05/08/2024 | SANOFI-AVENTIS U.S. LLC | TOUJEO (Biological) | Consulting Fee | Cash or cash equivalent | $11,820.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 11/02/2023 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Consulting Fee | Cash or cash equivalent | $9,926.00 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2022 | 1 | 14 | 16 | $4,080 | $797.72 |
| 2021 | 1 | 13 | 16 | $4,080 | $927.20 |
| 2020 | 1 | 12 | 15 | $3,825 | $671.85 |
All Medicare Procedures & Services
3 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 14 | 16 | $4,080 | $797.72 | 19.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Facility | 2021 | 13 | 16 | $4,080 | $927.20 | 22.7% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Facility | 2020 | 12 | 15 | $3,825 | $671.85 | 17.6% |
About Dr. Kevan Herold, MD
Dr. Kevan Herold, MD is a Endocrinology, Diabetes & Metabolism healthcare provider based in New Haven, Connecticut. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 10/03/2006. The National Provider Identifier (NPI) number assigned to this provider is 1083709463.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kevan Herold, MD has received a total of $170,878 in payments from pharmaceutical and medical device companies, with $68,149 received in 2024. These payments were reported across 70 transactions from 10 companies. The most common payment nature is "Consulting Fee" ($89,468).
As a Medicare-enrolled provider, Herold has provided services to 39 Medicare beneficiaries, totaling 47 services with total Medicare billing of $2,397. Data is available for 3 years (2020–2022), covering 3 distinct procedure/service records.
Practice Information
- Specialty Endocrinology, Diabetes & Metabolism
- Other Specialties Diabetes & Metabolism
- Location New Haven, CT
- Active Since 10/03/2006
- Last Updated 07/08/2007
- Taxonomy Code 207RE0101X
- Entity Type Individual
- NPI Number 1083709463
Products in Payments
- TOUJEO (Biological) $68,916
- TZIELD (Biological) $42,938
- SOLIQUA 100/33 (Biological) $3,600
- ORENCIA (Biological) $1,556
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Endocrinology, Diabetes & Metabolism Doctors in New Haven
Silvio Inzucchi, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $623,418
Philip Goldberg, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $428,337
Gerald Shulman, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $345,726
Karl Insogna, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $58,938
Dr. Adam Mayerson, M.d, M.D
Endocrinology, Diabetes & Metabolism — Payments: $27,516
Dr. Clemens Bergwitz, Md, MD
Endocrinology, Diabetes & Metabolism — Payments: $27,377